Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › AL › TUSCALOOSA › THE DCH HEALTHCARE AUTHORITY

THE DCH HEALTHCARE AUTHORITY

NPI: 1841394418 · TUSCALOOSA, AL 35401 · General Acute Care Hospital · NPI assigned 09/12/2006

$16.03M
Total Medicaid Paid
757,375
Total Claims
669,290
Beneficiaries
147
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHINDMAN, KERI (PATIENT ACCOUNTS DIRECTOR)
Parent OrganizationTHE DCH HEALTHCARE AUTHORITY
NPI Enumeration Date09/12/2006

Related Entities

Other providers sharing the same authorized official: HINDMAN, KERI

ProviderCityStateTotal Paid
FAYETTE MEDICAL CENTER FAYETTE AL $902K
THE DCH HEALTH CARE AUTHORITY TUSCALOOSA AL $182K
FAYETTE MEDICAL CENTER FAYETTE AL $102.19

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 136,188 $2.25M
2019 145,670 $2.50M
2020 91,792 $1.66M
2021 96,748 $1.86M
2022 97,273 $2.19M
2023 111,158 $3.19M
2024 78,546 $2.39M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 90,616 85,369 $3.39M
99284 Emergency department visit for the evaluation and management, high severity 49,607 46,416 $3.12M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 19,827 18,690 $2.04M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 7,548 7,009 $1.77M
80053 Comprehensive metabolic panel 61,655 53,945 $577K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 63,303 54,795 $477K
99282 Emergency department visit for the evaluation and management, low to moderate severity 13,233 11,408 $355K
11043 2,805 1,188 $296K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 7,973 7,532 $279K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 12,781 12,352 $276K
D9420 1,000 966 $255K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 12,740 10,948 $254K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 14,546 13,946 $205K
71046 Radiologic examination, chest; 2 views 17,101 16,152 $174K
81001 43,126 40,200 $164K
70450 Computed tomography, head or brain; without contrast material 1,911 1,760 $163K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 13,915 12,883 $150K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 56,099 41,428 $150K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room 124 123 $147K
87631 1,453 1,384 $108K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,710 2,544 $105K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,820 1,018 $100K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,289 3,148 $77K
87081 7,815 7,481 $69K
62323 746 507 $57K
81025 17,673 16,411 $56K
87634 952 892 $56K
88142 2,235 2,174 $53K
84466 5,549 5,015 $53K
87086 Culture, bacterial; quantitative colony count, urine 5,155 4,894 $52K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 2,233 2,103 $49K
71045 Radiologic examination, chest; single view 8,025 7,494 $45K
83690 6,493 6,067 $43K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,277 1,190 $42K
82607 4,216 3,750 $38K
J2505 Injection, pegfilgrastim, 6 mg 15 12 $35K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 828 776 $33K
84484 3,777 3,430 $33K
80306 2,740 2,520 $33K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 725 363 $32K
82553 2,049 1,853 $32K
82728 5,532 4,999 $32K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 240 120 $30K
82746 4,183 3,720 $28K
87807 2,006 1,924 $23K
86592 3,832 3,667 $23K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 694 621 $22K
83540 5,550 5,016 $22K
82550 2,474 2,222 $21K
83735 3,352 2,948 $20K
82077 1,824 1,629 $20K
80055 369 228 $19K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 983 941 $19K
83970 313 309 $16K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 631 601 $16K
85027 3,589 3,310 $14K
85045 4,592 4,125 $14K
59025 Fetal non-stress test 2,566 2,045 $13K
85610 3,335 3,131 $12K
59020 261 209 $12K
J0696 Injection, ceftriaxone sodium, per 250 mg 6,666 6,266 $10K
0001A 357 346 $9K
86703 537 510 $9K
86850 1,241 1,161 $8K
80048 Basic metabolic panel (calcium, ionized) 1,178 858 $8K
80061 Lipid panel 503 478 $8K
J1885 Injection, ketorolac tromethamine, per 15 mg 9,211 8,207 $8K
J7030 Infusion, normal saline solution , 1000 cc 4,102 3,461 $8K
86803 380 366 $8K
96367 475 255 $7K
86762 286 273 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 539 500 $7K
87340 433 414 $7K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 31,917 28,292 $7K
42820 Tonsillectomy and adenoidectomy; younger than age 12 12 12 $7K
85730 3,291 3,092 $6K
83036 Hemoglobin; glycosylated (A1C) 433 412 $6K
95811 29 25 $6K
83655 283 277 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor 106 98 $4K
G0378 Hospital observation service, per hour 73 52 $3K
84100 994 953 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 401 390 $3K
74177 Computed tomography, abdomen and pelvis; with contrast material 16 15 $3K
84702 262 235 $3K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,660 1,782 $3K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 2,105 1,094 $3K
95819 12 12 $3K
J2270 Injection, morphine sulfate, up to 10 mg 1,258 1,149 $2K
81003 1,032 970 $2K
82150 421 396 $2K
86900 690 644 $2K
86901 691 644 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,824 3,158 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 7,761 6,866 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 109 107 $2K
J7050 Infusion, normal saline solution, 250 cc 9,800 3,180 $2K
72125 Computed tomography, cervical spine; without contrast material 29 24 $2K
96375 Therapeutic injection; each additional sequential IV push 3,553 2,882 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 28 27 $2K
J1170 Injection, hydromorphone, up to 4 mg 854 666 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 13,330 12,415 $1K
86140 634 622 $1K
J2704 Injection, propofol, 10 mg 1,176 1,123 $1K
83880 27 26 $978.60
74022 40 39 $860.99
76801 34 31 $806.30
80050 General health panel 16 14 $766.50
84439 87 81 $756.75
83021 12 12 $585.84
84443 Thyroid stimulating hormone (TSH) 27 27 $497.81
84156 69 50 $348.29
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 97 97 $332.50
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 50 50 $331.40
83020 12 12 $300.84
82570 32 24 $230.62
82803 12 12 $228.24
82105 14 13 $227.07
72100 12 12 $219.23
84481 14 12 $171.70
82378 15 12 $161.52
J1040 Injection, methylprednisolone acetate, 80 mg 2,072 1,496 $155.87
83605 26 26 $145.73
J2550 Injection, promethazine hcl, up to 50 mg 93 85 $139.25
74018 12 12 $136.08
85660 12 12 $85.08
J2800 Injection, methocarbamol, up to 10 ml 1,855 1,328 $77.26
87210 12 12 $66.55
96361 Intravenous infusion, hydration; each additional hour 2,215 2,079 $60.88
J1650 Injection, enoxaparin sodium, 10 mg 18 12 $50.64
J2765 Injection, metoclopramide hcl, up to 10 mg 53 50 $40.39
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 12 12 $34.72
36415 Collection of venous blood by venipuncture 9,333 7,837 $32.91
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 43 29 $10.50
J2250 Injection, midazolam hydrochloride, per 1 mg 2,847 1,808 $8.72
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 3,449 3,089 $3.87
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,277 1,190 $0.00
J1644 Injection, heparin sodium, per 1000 units 49 29 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 14 12 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 359 341 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 150 132 $0.00
C1889 Implantable/insertable device, not otherwise classified 12 12 $0.00
J0690 Injection, cefazolin sodium, 500 mg 379 283 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 250 194 $0.00
11046 509 39 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 36 25 $0.00
94760 15 12 $0.00